Literature DB >> 8750018

A packaging cell line for propagation of recombinant adenovirus vectors containing two lethal gene-region deletions.

Q Wang1, X C Jia, M H Finer.   

Abstract

A cell line that provides the E1 as well as the E4 gene functions of human adenovirus 5 has been established by introduction of the full-length Ad5 E4 region into 293 cells. To avoid the E1A transactivation of the E4 gene expression, the E4 promoter was replaced by the mouse alpha inhibin promoter containing a cAMP response element. This cell line was used to generate E1/E4-deleted adenovirus vectors containing a lacZ gene in the E1 region under the control of mouse pgk promoter. The titer and the lacZ gene expression of E1/E4-deleted adenovirus vector were comparable to those of E1-deleted vectors. Evidence of cytopathic effect was absent following infection of nonpermissive cell lines with E1/E4-deleted adenovirus in vitro. Establishment of the 293-E4 cell line and the generation of E1/E4-deleted adenovirus vectors may prolong gene expression in vivo and significantly improve the safety of adenovirus vectors for human gene therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8750018

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  18 in total

1.  Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted.

Authors:  H Zhou; W O'Neal; N Morral; A L Beaudet
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

2.  Effect of the E4 region on the persistence of transgene expression from adenovirus vectors.

Authors:  D Armentano; J Zabner; C Sacks; C C Sookdeo; M P Smith; J A St George; S C Wadsworth; A E Smith; R J Gregory
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4.

Authors:  D E Brough; A Lizonova; C Hsu; V A Kulesa; I Kovesdi
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

4.  A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase.

Authors:  S Kochanek; P R Clemens; K Mitani; H H Chen; S Chan; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

5.  Conditional repression of the E2 transcription unit in E1-E3-deleted adenovirus vectors is correlated with a strong reduction in viral DNA replication and late gene expression in vitro.

Authors:  K Rittner; H Schultz; A Pavirani; M Mehtali
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  Diminishing adenovirus gene expression and viral replication by promoter replacement.

Authors:  B Fang; P Koch; J A Roth
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

7.  Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses.

Authors:  J F Dedieu; E Vigne; C Torrent; C Jullien; I Mahfouz; J M Caillaud; N Aubailly; C Orsini; J M Guillaume; P Opolon; P Delaere; M Perricaudet; P Yeh
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

8.  Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector.

Authors:  F Palombo; A Monciotti; A Recchia; R Cortese; G Ciliberto; N La Monica
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

9.  In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted.

Authors:  M Lusky; M Christ; K Rittner; A Dieterle; D Dreyer; B Mourot; H Schultz; F Stoeckel; A Pavirani; M Mehtali
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

10.  Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy.

Authors:  G P Gao; Y Yang; J M Wilson
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.